for Journals by Title or ISSN
for Articles by Keywords
help
Followed Journals
Journal you Follow: 0
 
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Jurnals are published.
Already have an account? Sign In to see the journals you follow.
Medtech Insight
   Journal TOC RSS feeds Export to Zotero Follow    
   Full-text available via subscription Subscription journal
     ISSN (Print) 1876-8008
     Published by Informa plc Homepage  [13 journals]
  • Innovation And Under-Penetration Driving Global Vascular Access Markets
    • Abstract: With an annual growth of almost 5%, the market for vascular access site repair products is attracting companies with innovative new products. Wider acceptance of new approaches to wound closure by interventionalists and the under-penetration in emerging Asian markets in particular are resulting in an uptake in the use of higher-tech devices and the emergence of local manufacturers.
      PubDate: Tue, 30 Sep 2014 00:05:27 -040
       
  • Who’s Next' Ten Potential Medtech Takeover Targets
    • Abstract: Device firms have already been active with M&A deals in 2014. Here are 10 companies to look for as potential acquisition targets going forward.
      PubDate: Tue, 30 Sep 2014 00:05:12 -040
       
  • Acquisitions, New Technologies Reshaping Advanced Wound Care
    • Abstract: Acquisitions and innovation are rapidly changing the dynamics in the global advanced wound care market, a high need, high growth market estimated at $5.4 billion in 2013. With the number of chronic wounds in major countries estimated at a whopping 26.7 million, the global advanced wound care market is projected to grow at a brisk 6% CAGR, reaching $7.3 billion by 2018.
      PubDate: Tue, 30 Sep 2014 00:05:03 -040
       
  • Google Moves Further Into Medical Device Space
    • Abstract: Google is making further inroads into the medical device space with deals designed to move the company’s two highly touted eyewear products into use by medical professionals. For Google’s smart contact lens, the company has partnered with Alcon to develop a glucose monitoring system, while Google Glass has become part of a project that will allow ambulance teams to transmit live views of patients in transit.
      PubDate: Tue, 30 Sep 2014 00:00:59 -040
       
  • BioVentrix Advances Its Revivent-TC Ventricular
           Enhancement Technology For Heart Failure
    • Abstract: BioVentrix Inc. has its sights set on US market approval for its hybrid transthoracic-endovascular Revivent-TC system, a unique device that enables a minimally invasive approach to treating patients who develop ischemic heart failure following a heart attack.
      PubDate: Tue, 30 Sep 2014 00:00:43 -040
       
  • Neuromod Devices: Self-Administered Neuromodulation For Tinnitus
    • Abstract: Neuromod Devices Ltd. has developed at-home neurostimulation treatment for subjective tinnitus that gradually aids the brain in distinguishing between real and false sounds by simultaneously stimulating the auditory and lingual nerves.
      PubDate: Tue, 30 Sep 2014 00:00:39 -040
       
  • Elute: Bone Filler Provides Sustained Antibiotic Release
    • Abstract: Elute Inc. is developing an antibiotic-releasing bone void filler designed to reduce the incidence of surgical site infections from primary and revised orthopedic procedures.
      PubDate: Tue, 30 Sep 2014 00:00:35 -040
       
  • ActiveProtective Technologies: Wearable Airbag Prevents Fractures
    • Abstract: Imagine wearing a belt containing an airbag that activates when you begin to fall, thus cushioning you from a hip fracture. ActiveProtective Technologies Inc. is developing just such a device that targets the frail and elderly population.
      PubDate: Tue, 30 Sep 2014 00:00:29 -040
       
  • Active Implants' NUsurface Meniscus Implant Starting
           IDE Clinical Trial
    • Abstract: Active Implant LLC is targeting the $1.5 billion annual global market for a meniscus replacement device with its NUsurface Meniscus Implant, and is starting an IDE clinical trial in the US.
      PubDate: Tue, 30 Sep 2014 00:00:21 -040
       
  • Masimo Root Monitoring System Gains FDA Clearance
    • Abstract: Masimo has gained FDA clearance for its Root Patient Monitoring Platform, a noninvasive, continuous monitoring platform with interoperability and technologies that have demonstrated improved patient safety and cost of care.
      PubDate: Tue, 30 Sep 2014 00:00:16 -040
       
  • Medical Device Deals Update, September 2014
    • Abstract: Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced in late July-September 2014.
      PubDate: Tue, 30 Sep 2014 00:00:08 -040
       
  • Medtech Execs On The Move, September 2014
    • Abstract: Recent executive-level company changes and promotions in the medical device and diagnostics industries.
      PubDate: Tue, 30 Sep 2014 00:00:01 -040
       
  • MIS 2014, Part 2: Opportunities And Challenges
    • Abstract: The increasing prevalence of MIS and the opportunity for greater MIS penetration in existing procedures translate into significant growth potential for the MIS products market in the years ahead. Despite some challenges, device manufacturers are driving growth in the market by targeting key procedures and geographies with new robotic surgery systems and robotic-like technologies designed to enable more complex procedures to be performed via an MIS approach.
      PubDate: Thu, 14 Aug 2014 00:05:27 -040
       
  • Peripheral Artery Disease: Treatments And Diagnostics Poised For Growth
    • Abstract: The market for peripheral vascular interventions and diagnostics is poised for significant growth in the years ahead, driven by an aging population and the growing incidence of peripheral vascular disease, along with new technological developments such as drug-eluting balloons, which are inching closer to regulatory approval in the US.
      PubDate: Thu, 14 Aug 2014 00:05:21 -040
       
  • ADA 2014: Diabetes Players Move Closer To An Artificial Pancreas
    • Abstract: The quest to bring an artificial pancreas to market has taken some giant steps forward recently, as major players continue to produce impressive data from clinical studies that measure the use of various insulin pumps, continuous glucose monitors (CGMs), and algorithms. Improvements in CGM sensor technology have helped move AP research, and competition is proving to be a driving force on the road to producing a commercial product that could be within two or three years from reaching the market.
      PubDate: Thu, 14 Aug 2014 00:05:00 -040
       
  • AxoGen: Advancing Regenerative Peripheral Nerve Repair
    • Abstract: AxoGen, with three commercially available peripheral nerve repair products, is looking to expand its horizons into new clinical areas and improve quality of life for patients with challenging nerve damage.
      PubDate: Thu, 14 Aug 2014 00:00:47 -040
       
  • OrthAlign’s “Smart” Navigation Device For Total Hip And
           Total Knee Arthroplasty
    • Abstract: OrthAlign has received 510(k) clearance for OrthAlign Plus, a palm-sized “smart” instrument designed to be a reliable and efficient alternative to expensive and bulky computer-assisted surgery systems.
      PubDate: Thu, 14 Aug 2014 00:00:44 -040
       
  • Inspire’s New Treatment Option For Obstructive Sleep Apnea
    • Abstract: Inspire Medical System Inc.’s new Inspire Upper Airway Stimulation system offers a new treatment option for the estimated one million patients in the US diagnosed with moderate-to-severe obstructive sleep apnea who are unable to tolerate continuous positive airway pressure.
      PubDate: Thu, 14 Aug 2014 00:00:39 -040
       
  • Covidien’s Strategies For MIS: An Interview With Chris Barry
    • Abstract: Chris Barry, president of Advanced Surgical Technologies at Covidien, discusses the company’s growth, strategies for increasing MIS penetration, and future directions.
      PubDate: Thu, 14 Aug 2014 00:00:35 -040
       
  • Spirox: Treating Nasal Obstruction Simply And Non-Surgically
    • Abstract: Faced with the large unmet clinical need of people with chronic nasal obstruction, an ENT physician formed Spirox to develop a non-surgical implant to restore the nasal valve. The ultimate goal is to develop a 15-minute procedure that ENTs can perform in their office to help patients breathe better.
      PubDate: Thu, 14 Aug 2014 00:00:30 -040
       
  • HeadSense Medical: Measuring Intracranial Pressure, Noninvasively
    • Abstract: Drilling a burr hole in the skull and placing a pressure sensor in the brain tissue is the unsettling but standard method for monitoring intracranial pressure in patients with severe traumatic brain injury or stroke. HeadSense Medical Ltd. has developed a noninvasive patient headset and tablet monitor that uses a low-frequency acoustic signal to automatically and continuously measure ICP.
      PubDate: Thu, 14 Aug 2014 00:00:26 -040
       
  • Anagnostics Bioanalysis: Integrated Sepsis Diagnostics
    • Abstract: Rather than waiting up to one full week to confirm suspected cases of sepsis through a routine blood test that uses conventional microbiology and the growing of bacteria or fungi, the hyborg cylindrical microarray platform from Austria’s Anagnostics Bioanalysis GMBH allows results in a mere four hours.
      PubDate: Thu, 14 Aug 2014 00:00:21 -040
       
  • Medical Device Deals Update, August 2014
    • Abstract: Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced June-July 2014.
      PubDate: Thu, 14 Aug 2014 00:00:15 -040
       
  • Medtech Execs On The Move, August 2014
    • Abstract: Recent executive-level company changes and promotions in the medical device and diagnostics industries.
      PubDate: Thu, 14 Aug 2014 00:00:11 -040
       
  • GE Healthcare’s Invenia: Improving Breast Cancer Detection In Dense
           Breasts
    • Abstract: GE Healthcare launched in June the Invenia Automated Breast Ultrasound System (ABUS), the first FDA-approved breast cancer screening option for women with dense breasts.
      PubDate: Thu, 14 Aug 2014 00:00:02 -040
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2014